WHO reported Increase in Rwanda Marburg virus disease incidence
On Oct. 11, 2024, the World Health Organization (WHO) reported that a total of 58 cases of Marburg…
-
-
Sabin Vaccine Institute Delivered Marburg Vaccines to Combat Outbreak in Rwanda
On Oct. 5, 2024, the Sabin Vaccine Institute announced it had provided its investigational Marburg vaccine to Rwanda…
-
Rwanda reports first-ever Marburg virus disease outbreak, with 26 cases confirmed
On Sept. 28, 2024, the World Health Organization (WHO) announced that Rwandan health authorities were intensifying outbreak control…
-
BioNTech and CEPI Expanded Partnership to Strengthen Africa’s mRNA Vaccine Ecosystem
On May 29, 2024, BioNTech and the Coalition for Epidemic Preparedness Innovations (CEPI) announced they were expanding their…
-
WHO reported Marburg virus disease outbreak in Equatorial Guinea
On Nov. 13, 2023, the World Health Organization (WHO announced that the Ministry of Health and Social Welfare…
-
Tanzania declared the end of its first documented outbreak of Marburg virus disease
On Jun. 2, 2023, the Ministry of Health of the United Republic of Tanzania declared the end of…
-
Additional cases of Marburg virus disease reported in Equatorial Guinea
On Apr. 17, 2023, the World Health Organization (WHO) announced that six additional laboratory-confirmed cases of Marburg virus…
-
Tanzania declared an outbreak of Marburg virus disease
On Mar. 21, 2023, the Ministry of Health of the United Republic of Tanzania declared an outbreak of…
-
Equatorial Guinea confirmed first-ever Marburg virus disease outbreak
On Feb. 13, 2023, Equatorial Guinea today confirmed its first-ever outbreak of Marburg virus disease. Preliminary tests carried…
-
Ebola trial candidate vaccines arrived in Uganda in record 79 days after outbreak declared
On Dec. 9, 2022, the World Health Organization (WHO) announced that the first doses of one of the…
-
Ghana declared first-ever outbreak of Marburg virus disease
On Jul. 17, 2022, Ghana announced the preliminary finding of two cases of Marburg virus disease and if…
-
Ghana reported first-ever suspected cases of Marburg virus disease
On Jul. 7, 2022, Ghana announced the preliminary finding of two cases of Marburg virus disease and if…
-
NIH announced antiviral drug development awards
On May 18, 2022, the U.S. National Institutes of Health announced it had awarded approximately $577 million to…
-
WHO reported Ebola virus disease in Democratic Republic of the Congo
On Apr. 28, 2022, the Ministry of Health of the Democratic Republic of the Congo declared an outbreak…
-
BioNTech introduced first modular mRNA manufacturing facility to promote scalable vaccine production in Africa
On Feb. 16, 2022, BioNTech announced it had introduced its approach to establishing scalable vaccine production by developing…
-
Guinea declared end of Marburg virus disease outbreak
On Sept. 15, 2021, Guinea declared the end of the Marburg virus disease outbreak having recorded no new…
-
West Africa’s first-ever case of Marburg virus disease confirmed in Guinea
On Aug. 9, 2021, health authorities in Guinea confirmed a case of Marburg virus disease in the southern…
-
The 12th Ebola outbreak in the Democratic Republic of the Congo declared over
On May 3, 2021, the World Health Organization (WHO) announced the end of the 12th Ebola outbreak in…
-
BioNTech updated on vaccine production status at Marburg manufacturing site
On Mar. 26, 2021, BioNTech announced that the European Medicines Agency (EMA) approved the manufacturing of the COVID-19…
-
BioNTech updated vaccine production manufacturing site in Marburg, Germany
On Feb. 10, 2021, BioNTech announced they had increased their manufacturing capacity in Marburg, Germany to up to…
-
11th Ebola outbreak in the Democratic Republic of the Congo declared over
On Nov. 18, 2020, marks the end of the 11th Ebola outbreak in the Democratic Republic of the…
-
BioNTech acquired GMP manufacturing site to expand COVID-19 vaccine production
On Sept. 17, 2020, BioNTech announced an agreement with Novartis to acquire their GMP certified manufacturing facility in…
-
Soligenix announced publication demonstrating thermostabilization of filovirus vaccine antigens
On Sept. 15, 2020, Soligenix announced publication of nonclinical results characterizing filovirus protein antigens (including for Ebola and…
-
No link between two ongoing Ebola outbreaks in the Democratic Republic of the Congo
On Jun. 9, 2020, genetic sequence analysis by the Democratic Republic of the Congo’s (DRC) National Institute of…
-
Biotechnology | Diagnostics | Infectious Disease | Measles | Vaccine | WHO
New Ebola outbreak detected in northwest Democratic Republic of the Congo
On Jun. 1, 2020,The Government of the Democratic Republic of the Congo announced that a new outbreak of…
-
IAVI and Merck announced collaboration to develop vaccine against SARS-CoV-2
On May 26, 2020, Merck and and IAVI, a nonprofit scientific research organization dedicated to addressing urgent, unmet…
-
FDA accepted for Priority Review Biologics License Application for REGN-EB3 to treat Ebola
On Apr. 16, 2020, Regeneron announced the U.S. Food and Drug Administration (FDA) had accepted for Priority Review…
-
Soligenix and University of Hawaii at Manoa initiate work on novel Coronavirus vaccine for COVID-19
On Mar. 23, 2020, Soligenix announced that its ongoing collaboration with the University of Hawaii at Manoa (UH…
-
CDC | Diagnostics | HIV | Infectious Disease | Therapeutics
The CDC established the International Health Program Office
In 1981, the U.S. Centers for Disease Control and Prevention (CDC) established the International Health Program Office, now…
-
Biology | CDC | Diagnostics | Infectious Disease | Life Science History | NIH | Plague | Therapeutics | Vaccine
The CDC opened an expanded maximum containment lab (hot lab) for highly dangerous viruses
In 1978, the U.S. Centers for Disease Control and Prevention (CDC) completed construction of a new hot lab…
